XML 31 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Details 2) (Alvos Therapeutics [Member], USD $)
Jun. 30, 2012
Alvos Therapeutics [Member]
 
Summary of estimated fair values at the date of acquisition  
Current assets $ 29,332
In-process R&D 2,083,701
Current liabilities (113,033)
Total purchase consideration $ 2,000,000